Original language | English (US) |
---|---|
Pages (from-to) | 1012 |
Number of pages | 1 |
Journal | JAMA cardiology |
Volume | 6 |
Issue number | 9 |
DOIs |
|
State | Published - Sep 2021 |
Funding
reported receiving grants from Amgen, Apple, Boston Scientific, and AstraZeneca; personal fees from Apple, Blackstone Life Sciences, Novartis, Genentech/Roche, AstraZeneca, and Foresite Labs; and spousal employment at Vertex outside the submitted work. Dr McNally reported receiving grants from the National Institutes of Health to Northwestern University and from the American Heart Association to Northwestern University during the conduct of the study and personal fees from Amgen, Avidity, AstraZeneca, Cytokinetics, 4D Molecular Therapeutics, Pfizer, Janssen, Tenaya, and Invitae outside the submitted work and is the founder of Ikaika Therapeutics, which is unrelated to the content of manuscript. No other disclosures were reported.
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine